• Users Online: 130
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2020  |  Volume : 2  |  Issue : 1  |  Page : 5-7

Chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease


Department of Microbiology, Al-Amiri Hospital, Kuwait City, Kuwait

Correspondence Address:
Dr. Deepthi Nair
Department of Microbiology, Al-Amiri Hospital, Kuwait City
Kuwait
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ACCJ.ACCJ_5_20

Rights and Permissions

COVID-19 is a zoonotic viral infection caused by severe acute respiratory syndrome coronavirus-2. Although the management of COVID-19 infection is mainly supportive, the arena of infective therapy now also includes drugs such as chloroquine and its substitute, hydroxychloroquine, which are believed to have antiviral properties in addition to their antimalarial and immunomodulating effects. The objective of this review article is to focus on the antiviral effect of chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed227    
    Printed15    
    Emailed0    
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal